Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI

Neurology

Volumn 78, Issue 9, 2012, Pages 618-625

  Gupta, R K ^a   Awasthi, R ^a   Rathore, R K S ^b   Verma, A ^a   Sahoo, P ^b   Paliwal, V K ^a   Prasad, K N ^a   Pandey, C M ^a   Narayana, P A ^c  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ADOLESCENT; ADULT; ARTICLE; BRAIN CALCIFICATION; CHILD; CLINICAL ARTICLE; ENZYME ANALYSIS; EPILEPSY; EPILEPTOGENESIS; FEMALE; HUMAN; MALE; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PIG FARMING; PRIORITY JOURNAL; SEIZURE;

EID: 84858166708     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318248deae     Document Type: Article

References (30)

1. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004;62: 1934-1938. (Pubitemid 38738199)
2. Garcia NJ, Moreno E, de Mata F, et al. Epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol 2001;95:167-175.
3. Prasad A, Gupta RK, Pradhan S, et al. What triggers seizures in neurocysticercosis? A MRI-based study in pig farming community from a district of North India. Parasitol Int 2008;57:166 -171.
4. Nash TE, Patronas NJ. Edema associated with calcified lesions in neurocysticercosis. Neurology 1999;53:777-781. (Pubitemid 29448299)
5. Gupta RK, Kumar R, Chawla S, Pradhan S. Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia 2002;43:1502-1508. (Pubitemid 35429768)
6. Agarwal A, Raghav S, Husain M, et al. Epilepsy with focal cerebral calcification: role of magnetization transfer MR imaging. Neurol India 2004;52:197-199. (Pubitemid 39136950)
7. Antoniuk SA, Bruck I, Dos Santos LH, et al. Seizures associated with calcifications and edema in neurocysticercosis. Pediatr Neurol 2001;25:309 -311.
8. Tsenova L, Bergtold A, Freedman VH, et al. Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA 1999;96:5657-5662. (Pubitemid 29234674)
9. trans) is a surrogate marker of matrix metalloproteinase 9 expression in brain tuberculoma. J Magn Reson Imaging 2008;28:588-597.
10. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metallo-proteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617- 629.
11. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21:7724 - 7732.
12. Alvarez JI, Teale JM. Breakdown of the blood brain barrier and blood- cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J Neuroimmunol 2006;173:45-55.
13. Chawla S, Husain N, Kumar S, et al. Correlative MR imaging and histopathology in porcine neurocysticercosis. J Magn Reson Imaging 2004;20:208 -215.
14. Sikasunge CS, Johansen MV, Phiri IK, et al. The immune response in Taenia solium neurocysticercosis in pigs is associated with astrogliosis, axonal degeneration and altered blood-brain barrier permeability. Vet Parasitol 2009;160:242-250.
15. Jackson A. Imaging microvascular structure with contrast enhanced MRI. Br J Radiol 2003;76:159 -173.
16. 1 dynamic contrast enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 2007;26:871- 880.
17. Zhao Q, Lee S, Kent M, et al. Dynamic contrast-enhanced magnetic resonance imaging of canine brain tumors. Vet Radiol Ultrasound 2010;51:122-129.
18. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50 -59.
19. Garcia HH, Gonzalez AE, Gilman RH, et al. Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Am J Trop Med Hyg 2002;66:427-430. (Pubitemid 34810499)
20. Del Brutto OH. Neurocysticercosis Semin Neurol 2005;25:243-251. (Pubitemid 41437619)
21. Miller SA, Dykes DD, Polesky HF. A Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
22. Beránek M, Kolar P, Tschoplova S, et al. Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy. Mol Vis 2008;14:1114 -1121.
23. Nash TE, Pretell EJ, Lescano AG, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 2008;7:1099 -1105.
24. Gupta RK, Kathuria MK, Pradhan S. Magnetization transfer magnetic resonance imaging demonstration of perilesional gliosis-relation with epilepsy in treated or healed neurocysticercosis. Lancet 1999;354:44-45. (Pubitemid 29304305)
25. Escobar A, Weidenheim KM. The pathology of neurocysticercosis. In: Singh G, Prabhakar S, eds. Taenia solium Cysticercosis: From Basic to Clinical Science. New York: CAB International; 2002:289 -305.
26. Chacko G, Rajshekhar V, Chandy MJ, Chandi SM. The calcified intracorporeal vacuole: an aid to the pathological diagnosis of solitary cerebral cysticercus granulomas. J Neurol Neurosurg Psychiatry 2000;69:525-527.
27. White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu RevMed2000; 51:187-206.
28. Chaudhary AK, Singh M, Bharti AC, et al. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci 2010;17:10.
29. Wu J, Zhang L, Luo H, et al. Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma. DNA Cell Biol 2008;27:553-557.
30. Vairaktaris E, Vassiliou S, Nkenke E, et al. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 2008;34:450-455. (Pubitemid 351391904)